Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321 | ISIN: INE010B01027 | Industry: Pharmaceuticals
| Mid-range Performer
910.7000 8.45 (0.94%)
NSE Apr 10, 2026 10:41 AM
Volume: 199.6K
 

910.70
0.94%
Phillip Capital
growth was +6% yoy (vs estimated 8%). EBITDA margin at 21.9% was 120bps below our estimates of 23.1%. The PAT (adjusted forforex gain ofRs448mn) declined 14% yoyto Rs 3.21bn(implying20%/17%misstoour/consensusestimates).InQ1FY17,CDHhasremoved JVsalesfromconsolidatedsalesandbookedtheshareofprofitfromJVsasperINDAS.Ifwe...
Zydus Lifesciences Ltd. is trading above its 100 day SMA of 907.7
More from Zydus Lifesciences Ltd.
All Rapid Results
Recommended